We evaluated the effects of SOM on primed lymph node T cells, with a T-cell culture assay previously reported.
6 25 Briefly, we collected cells from mouse lymph nodes that drain tissue sites injected with Freund’s adjuvant containing 10 mg/mL
Mycobacterium tuberculosis (Difco Laboratories, Detroit, MI). T cells were enriched using a T-cell column (R&D Systems). This method obtained 99% CD3
+ cells by flow cytometry analysis. The T cells (4 × 10
5 cells) were added to the wells of a 96-well, round-bottomed plate (Corning Costar) along with SOM and 1 μg/mL anti-CD3ε antibody (145-2C11; BD PharMingen, San Diego, CA) in serum-free medium. The concentration of anti-CD3ε antibody was optimized for IFN-γ production and proliferation by primed lymph node T cells. At this concentration, the antibody did not stimulate naive lymph node T cells, which required 10 times more antibody to be stimulated. The serum-free culture medium
5 was RPMI 1640, 0.1% BSA solution (Sigma, St. Louis, MO), and a 1:500 dilution of ITS+1 solution (Sigma). The cultures were incubated for 48 hours at 37°C in 5% CO
2, and the supernatants were assayed for lymphokines using sandwich ELISA specific for IFN-γ or IL-4. The supernatant was also assayed for TGF-β using the standard Mv1Lu (CCL-64 cell line; from ATCC, Manassas, VA) bioassay for TGF-β. The lymphokine assays are described in detail in the next section. For the proliferation assay, the T-cell cultures were initially incubated for 24 hours, 20 μL of 50 μCi/mL [
3H]thymidine (NEN, Boston, MA) was added to the wells, and the cultures were incubated for an additional 24 hours. The cells were collected onto filter paper by a plate harvester (Tomtec, Hamden, CT), and radiolabel was measured with a liquid scintillation counter (Betaplate; Wallac, Gaithersburg, MD).